Flagship explainer
What drives Amphastar Pharmaceuticals, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $98.1M | FY2025 |
| |
| Income before tax | $124M | FY2025 |
|
| Operating income | $140M | FY2025 |
|
| $720M | FY2025 |
| |
| Ending assets | $1.6B | FY2025 |
|
| Beginning assets | $1.6B | FY2024 |
|
| $789M | FY2025 |
| |
| $732M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001297184-25-000008
- SEC filingFiling detailsAccession 0001297184-26-000009